Management of Recent Cerebellar Infarct with Suspected Petechial Hemorrhage
Antiplatelet Management
Continue aspirin therapy in this patient with a recent cerebellar infarct and suspected petechial hemorrhage, as the benefits of stroke prevention outweigh the risk of hemorrhagic transformation in a stable patient with mild symptoms. 1
The management approach for this 54-year-old male with a recent cerebellar infarct (less than half of cerebellar hemisphere) and suspected petechial hemorrhage should be guided by the following considerations:
Aspirin Continuation
- Continue aspirin therapy as the patient is fully conscious, stable, and has only mild ataxia
- The presence of small petechial hemorrhage is not a contraindication to continuing antiplatelet therapy when the patient is neurologically stable 1
- Aspirin at doses of 81-325 mg daily is appropriate for secondary stroke prevention in non-cardioembolic ischemic events 1
Dual Antiplatelet Therapy (DAPT) Considerations
- DAPT is not indicated in this case for several reasons:
- The patient's stroke occurred 24 hours ago (outside the optimal window for DAPT initiation)
- DAPT is primarily recommended for minor ischemic stroke (NIHSS ≤3) or high-risk TIA when initiated within 12-24 hours of symptom onset 2
- The presence of petechial hemorrhage raises concerns about increased bleeding risk with DAPT
- World Stroke Organization guidelines do not strongly recommend DAPT over single antiplatelet therapy for patients with cerebellar infarcts 1
Neuroimaging Recommendations
Timing of Repeat Imaging
- Repeat neuroimaging should be performed at 24-72 hours after initial presentation to:
- Assess for hemorrhagic transformation
- Evaluate for progression of infarct size
- Monitor resolution of petechial hemorrhage
Type of Imaging
- MRI with diffusion-weighted imaging is the preferred modality for follow-up imaging because:
- MRI is superior to CT for detecting both acute and chronic intracerebral hemorrhage (96% concordance for acute hemorrhage) 3
- MRI provides better visualization of posterior fossa lesions, particularly important for cerebellar infarcts 4
- MRI can better characterize the extent of the infarct and any associated hemorrhagic transformation
Need for Vascular Imaging
- CTA or MRA is indicated to evaluate the vertebrobasilar system because:
- Identifying the underlying etiology is crucial for secondary prevention strategies
- American Heart Association/American Stroke Association guidelines recommend CTA or MRA rather than ultrasound for evaluation of vertebral arteries in patients with posterior circulation symptoms 1
- Vascular imaging can detect vertebrobasilar stenosis, dissection, or other pathologies that might require specific management
Additional Management Considerations
- Blood pressure management: Target systolic blood pressure <140 mmHg 1
- Lipid management: High-dose statin therapy is recommended 1
- Physical activity: At least moderate physical activity should be encouraged once stable 1
- Monitor for neurological deterioration, as cerebellar infarcts can lead to edema and obstructive hydrocephalus
Pitfalls and Caveats
- Do not discontinue aspirin based solely on the presence of petechial hemorrhage in a stable patient, as this increases risk of recurrent ischemic events
- Avoid initiating DAPT outside the recommended time window (>24 hours after symptom onset) as this increases bleeding risk without proven benefit
- Do not rely solely on CT for follow-up imaging of posterior fossa lesions, as it has limited sensitivity compared to MRI
- Remember that cerebellar infarcts can deteriorate rapidly due to edema and mass effect, requiring close monitoring even in initially stable patients